The second category includes disease management, controlling blood sugar in diabetic neuropathy, adjusting chemotherapy regimens, or treating underlying infections
Drug selection, including whether to use either alone or in combination, is an individualized medical decision made during evaluation
Other Popular Peptides in the Gray Zone: Thymosin Alpha-1 Immune support (approved in 35+ countries, NOT in US) GHK-Cu (Copper Peptide) Skin/hair (injectable form banned by FDA) Epitalon Claimed anti-aging (no human studies) LL-37 Antimicrobial (research only) AOD-9604 Fat loss (FDA banned) Semorelin Growth hormone release Melanotan II Tanning (serious side effects) The FDA Crackdown: What Happened in Late 2023 Timeline of the Ban: 2023: FDA adds 12+ peptides to "Category 2 Bulk Drug Substances" list What this means: Compounding pharmacies CANNOT legally make these peptides FDA cites "significant safety risks" No approved use in humans Peptides specifically banned from compounding: BPC-157 TB-500 (Thymosin Beta-4 fragment) Thymosin Alpha-1 CJC-1295 Ipamorelin AOD-9604 GHK-Cu (injectable) Epitalon LL-37 DSIP KPV Selank Semax And more

if you expose it to liquid too forcefully or shake it violently, you risk damaging the molecular structure (denaturation), which can undermine research quality
Browse Products at HCR Health
If you work in sports medicine or regenerative health, youve heard about BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu